Detecting Compaction Disequilibrium with Anisotropy of Magnetic Susceptibility

In clay-rich sediment, microstructures and macrostructures influence how sediments deform when under stress. When lithology is fairly constant, anisotropy of magnetic susceptibility (AMS) can be a simple technique for measuring the relative consolidation state of sediment, which reflects the sediment burial history. AMS can reveal areas of high water content and apparent overconsolidation associated with unconformities where sediment overburden has been removed. Many other methods for testing consolidation and water content are destructive and invasive, whereas AMS provides a nondestructive means to focus on areas for additional geotechnical study. In zones where the magnetic minerals are undergoing diagenesis, AMS should not be used for detecting compaction state. By utilizing AMS in the Santa Barbara Basin, we were able to identify one clear unconformity and eight zones of high water content in three cores. With the addition of susceptibility, anhysteretic remanent magnetization, and isothermal remanent magnetization rock magnetic techniques, we excluded 3 out of 11 zones from being compaction disequilibria. The AMS signals for these three zones are the result of diagenesis, coring deformation, and burrows. In addition, using AMS eigenvectors, we are able to accurately show the direction of maximum compression for the accumulation zone of the Gaviota Slide

The Magellanic Mopra Assessment (MAGMA). I. The Molecular Cloud Population of the Large Magellanic Cloud

We present the properties of an extensive sample of molecular clouds in the Large Magellanic Cloud (LMC) mapped at 11 pc resolution in the CO(1-0) line. We identify clouds as regions of connected CO emission, and find that the distributions of cloud sizes, fluxes and masses are sensitive to the choice of decomposition parameters. In all cases, however, the luminosity function of CO clouds is steeper than dN/dL \propto L^{-2}, suggesting that a substantial fraction of mass is in low-mass clouds. A correlation between size and linewidth, while apparent for the largest emission structures, breaks down when those structures are decomposed into smaller structures. We argue that the correlation between virial mass and CO luminosity is the result of comparing two covariant quantities, with the correlation appearing tighter on larger scales where a size-linewidth relation holds. The virial parameter (the ratio of a cloud's kinetic to self-gravitational energy) shows a wide range of values and exhibits no clear trends with the CO luminosity or the likelihood of hosting young stellar object (YSO) candidates, casting further doubt on the assumption of virialization for molecular clouds in the LMC. Higher CO luminosity increases the likelihood of a cloud harboring a YSO candidate, and more luminous YSOs are more likely to be coincident with detectable CO emission, confirming the close link between giant molecular clouds and massive star formation.Comment: Accepted by ApJS; 22 pages in emulateapj format; full-resolution version and data tables available at http://mmwave.astro.illinois.edu/magma

Inherited chromosomally integrated human herpesvirus 6 genomes are ancient, intact and potentially able to reactivate from telomeres

The genomes of human herpesviruses 6A and 6B (HHV-6A and HHV-6B) have the capacity to integrate into telomeres, the essential capping structures of chromosomes that play roles in cancer and ageing. About 1% of people worldwide are carriers of chromosomally integrated HHV-6 (ciHHV-6), which is inherited as a genetic trait. Understanding the consequences of integration for the evolution of the viral genome, for the telomere and for the risk of disease associated with carrier status is hampered by a lack of knowledge about ciHHV-6 genomes. Here, we report an analysis of 28 ciHHV-6 genomes and show that they are significantly divergent from the few modern non-integrated HHV-6 strains for which complete sequences are currently available. In addition ciHHV-6B genomes in Europeans are more closely related to each other than to ciHHV-6B genomes from China and Pakistan, suggesting regional variation of the trait. Remarkably, at least one group of European ciHHV-6B carriers has inherited the same ciHHV-6B genome, integrated in the same telomere allele, from a common ancestor estimated to have existed 24,500 ±10,600 years ago. Despite the antiquity of some, and possibly most, germline HHV-6 integrations, the majority of ciHHV-6B (95%) and ciHHV-6A (72%) genomes contain a full set of intact viral genes and therefore appear to have the capacity for viral gene expression and full reactivation. IMPORTANCE: Inheritance of HHV-6A or HHV-6B integrated into a telomere occurs at a low frequency in most populations studied to date but its characteristics are poorly understood. However, stratification of ciHHV-6 carriers in modern populations due to common ancestry is an important consideration for genome-wide association studies that aim to identify disease risks for these people. Here we present full sequence analysis of 28 ciHHV-6 genomes and show that ciHHV-6B in many carriers with European ancestry most likely originated from ancient integration events in a small number of ancestors. We propose that ancient ancestral origins for ciHHV-6A and ciHHV-6B are also likely in other populations. Moreover, despite their antiquity, all of the ciHHV-6 genomes appear to retain the capacity to express viral genes, and most are predicted to be capable of full viral reactivation. These discoveries represent potentially important considerations in immune-compromised patients, in particular in organ transplantation and in stem cell therapy

Lonafarnib improves cardiovascular function and survival in a mouse model of Hutchinson-Gilford progeria syndrome

Clinical trials have demonstrated that lonafarnib, a farnesyltransferase inhibitor, extends the lifespan in patients afflicted by Hutchinson-Gilford progeria syndrome, a devastating condition that accelerates many characteristics of aging and results in premature death due to cardiovascular sequelae. The US Food and Drug Administration approved Zokinvy (lonafarnib) in November 2020 for treating these patients, yet a detailed examination of drug-associated effects on cardiovascular structure, properties, and function has remained wanting. In this paper, we report encouraging outcomes of daily post-weaning treatment with lonafarnib on the composition and biomechanical phenotype of elastic and muscular arteries as well as associated cardiac function in a well-accepted mouse model of progeria that exhibits severe perimorbid cardiovascular disease. Lonafarnib resulted in 100% survival of the treated progeria mice to the study end-point (time of 50% survival of untreated mice), with associated improvements in arterial structure and function working together to significantly reduce pulse wave velocity and improve left ventricular diastolic function. By contrast, neither treatment with the mTOR inhibitor rapamycin alone nor dual treatment with lonafarnib plus rapamycin improved outcomes over that achieved with lonafarnib monotherapy